ABSTRACT
Objective To investigate the frequency of diagnoses seen among new referrals to neurology outpatient services; to understand how these services are used through exploratory analysis of diagnostic tests and follow-up appointments; and to examine the waiting times between referral and appointment.
Methods Routine data from new NHS appointments at a single consultant-delivered clinic between Sept 2016 and January 2019 were collected. These clinical data were then linked to hospital administrative data. The combined data were assigned diagnostic categories based on working diagnoses to allow further analysis using descriptive statistics.
Results Five diagnostic categories accounted for 62% of all patients seen within the study period, the most common of which was headache disorders. Following a first appointment, 50% of all patients were offered at least one diagnostic test, and 35% were offered a follow-up appointment, with variation in both measures by diagnostic category. Waiting times from referral to appointment also varied by diagnostic category. 65% of patients with a seizure/epilepsy disorder were seen within the 18 week referral to treatment target, compared to 38% of patients with a movement disorder.
Conclusions A small number of diagnostic categories account for a large proportion of new patients. This information could be used in policy decision making to describe a minimum subset of categories for diagnostic coding. We found significant differences in waiting times by diagnostic category, as well as tests ordered, and follow-up offered; further investigation could address causes of variation.
Competing Interest Statement
Fran Biggin received a grant from EPSRC. Prof Knight and Prof Emsley are funded by Lancaster University
Funding Statement
Fran Biggin is funded by an EPSRC doctoral training partnership grant number EP/R513076/1.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
HRA approval granted on 30 May 2019 (Ref: 255676). Lancaster University Faculty of Health and Medicine Research Ethics Committee approval granted on 17 June 2019 (Ref: FHMREC18092).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
f.biggin{at}lancaster.ac.uk, Timothy.Howcroft{at}lthtr.nhs.uk, Quinta.Davies{at}lthtr.nhs.uk, hedley.emsley{at}lancaster.ac.uk
Data Availability
Due to patient data confidentiality and restrictions imposed by the HRA we are unable to directly share the data for this study. Anyone wishing to access this data must apply to do so through the HRA by completing an IRAS application.
